A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to implement. The effective Pharma strategies can help to generate business exposure, relationship building, and market research. Thus, they are important initiatives to boom overall business in the long term.
Generic and innovator pharmaceutical companies have stark differences such as times resources and costs allocated to launch products
In the first article in this series I began from the premise that as soon as any life sciences firm moves significantly outside its home market it faces the glocalisation challenge the dilemma between global opportunities and local needs
While COVID is not yet behind us there has never been a better time to consider the meaning of national resilience and to prepare for the next threat
Do more better and faster research Scientific researchers have always generally acknowledged the importance of collaboration and sharing of scientific findings to advance scientific innovation
Screening strategies for small molecules have evolved over decades to pan through thousands of molecules in silico and in highthroughput in vitro assays using the smallest possible amount of compound at minimal cost
Navigating the complex challenges of bringing new medicines to the marketplace requires both leadership and effective decisionmaking
Over the last three decades pharma companies have increasingly relied on outsourced research to minimise costs and incorporate new science relating directly to the better understanding of biology
The pharmaceutical industry has changed dramatically since I first stood at a laboratory bench in the s
For the pharmaceutical industry managing supply chain risk has never been a higher priority
One of the most important tasks of any regulatory body is to ensure that pharmaceutical products are developed in accordance with the localregional regulatory requirements
